Amino acid solution
Sponsors
B.P. Koirala Institute of Health Sciences, Ipsen, Molecular Targeting Technologies, Inc., ITM Solucin GmbH, Grupo Espanol de Tumores Neuroendocrinos
Conditions
CNS TumorsGISTGrade1-2 Advanced Midgut Neuroendocrine Tumors (NETs)Hepatic FailureHypothermiaLiver TransplantLymphomaNETs
Phase 1
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
TerminatedNCT02592707
Start: 2017-03-06End: 2022-02-22Updated: 2023-07-19
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
RecruitingNCT05475210
Start: 2022-06-18End: 2025-03-30Target: 9Updated: 2024-03-13
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
RecruitingNCT06441331
Start: 2025-09-26End: 2034-04-30Target: 20Updated: 2025-12-17
Phase 3
Unknown Phase
Amino Acid Infusion in Mothers Before and During Cesarean Delivery
CompletedNCT02575170
Start: 2013-06-30End: 2016-04-30Updated: 2019-03-15
Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
Not yet recruitingNCT07004387
Start: 2025-05-27End: 2026-09-30Target: 90Updated: 2025-06-04